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Purpose: Systemic lupus erythematosus (SLE) is an autoimmune connective tissue disease that can affect the cen-
tral nervous system. Neuropsychiatric symptoms are found in 25–70% of patients. Using diffusion tensor imaging
(DTI) various studies have reported changes in white matter integrity in SLE patients with neuropsychiatric
symptoms (NPSLE patients). The purpose of this study was to investigate, if regional changes in white matter in-
tegrity can also be detected in SLE patients without neuropsychiatric symptoms (non-NPSLE patients).
Methods: Applying DTI and tract based spatial statistics (TBSS) we investigated 19 NPSLE patients, 19 non-NPSLE
and 18 healthy controls. Groups were matched for age and sex. Image pre-processing was performed using FSL,
following the TBSS pipeline (eddy current correction, estimation of fractional anisotropy (FA), normalization,
skeletonization of the group mean FA image). A general linear model with threshold-free cluster enhancement
was used to assess signiﬁcant differences between the three groups.
Results: Statistical analyses revealed several regions of decreased prefrontal white matter integrity (decreased
FA) in both groups of SLE patients. The changes found in the non-NPSLE patients (as compared to healthy con-
trols) overlapped with those in the NPSLE patients, but were not as pronounced.
Conclusions: Our data suggest that changes in regional white matter integrity, in terms of a decrease in FA, are
present not only in NPSLE patients, but also in non-NPSLE patients, though to a lesser degree. We also demon-
strate that the way statistical maps are corrected for multiple comparisons has a profound inﬂuence on whether
alterations in white matter integrity in non-NPSLE patients are deemed signiﬁcant.
© 2014 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Systemic lupus erythematosus (SLE) is a chronic inﬂammatory,
immune-mediated disease, which affects 0.05–0.1% of the general pop-
ulation (Somers et al., 2014; Bernatsky et al., 2007). Neuropsychiatricy; CNS, central nervous system;
tional anisotropy;MRI,magnet-
sus; SLEDAI, Systemic Lupus
temic lupus erythematosus
; SVM, support vector machine;
ster enhancement; VBM, voxel
, Bergmannsheil, Bürkle-de-la-
l.de (T. Schmidt-Wilcke).
. This is an open access article undersymptoms have been reported to occur in 25–70% of patients with
SLE (Brey et al., 2002; Monastero et al., 2001) and are associated
with increased morbidity and mortality (Sibley et al., 1992;
Gladman et al., 1996). Magnetic resonance imaging (MRI) has be-
come part of the routine clinical work up in SLE patients presenting
with neuropsychiatric symptoms (NPSLE patients) (Appenzeller et al.,
2008a,b; Steup-Beekman et al., 2013), helping to diagnose or exclude ce-
rebral pathologies such as edema, hemorrhage, central thrombosis, or
stroke.
Using quantitative analysis methods, changes in brain chemistry
(Sundgren et al., 2005; Appenzeller et al., 2007a), regional cerebral
blood ﬂow (Shen et al., 1999; Oda et al., 2005; Wang et al., 2012) and
cerebral glucose utilization (Otte et al., 1997) have been demonstrated
in NPSLE patients. Structural brain imaging methods, such as voxel
based morphometry (VBM), cortical thickness analysis and diffusion
tensor imaging (DTI), have also been applied to investigate differencesthe CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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(HCs) (Appenzeller et al., 2007a; Jung et al., 2010; Emmer et al., 2010;
Welsh et al., 2007). Regions of altered brain structure, in terms of de-
creases in regional gray matter volume, cortical thickness or fractional
anisotropy (FA) have been demonstrated in NPSLE patients, but less fre-
quently in non-NPSLE patients (Appenzeller et al., 2007a; Jung et al.,
2010; Jung et al., 2010).
The distinction between NPSLE and non-NPSLE is clinical, based on
theAmerican College of Rheumatology (ACR) case deﬁnitions. In clinical
practice brain imaging is often not part of the routine work up of non-
NPSLE, possibly leading to an underestimation of CNS disease. Some au-
thors, usingMR imaging, have found evidence for small emboli, cerebral
infarctions, hemosiderin deposits, and dilated perivascular spaces in up
to 60% of non-NPSLE patients, strongly suggesting cerebral involvement
in at least some of these patients (Cotton et al., 2004). Along these lines
spectroscopy studies have reported decreased NAA levels, indicative of
axonal dysfunction/damage, in SLE patients with active disease, inde-
pendently of CNS manifestation (Sundgren et al., 2005; Appenzeller
et al., 2005; Cagnoli et al., 2013). On the other hand some of the
studies using advanced statistical imaging methods, such as VBM and
DTI, have detected reduced gray or white matter integrity in NPSLE pa-
tients only, but not in non-NPSLE patients, suggesting that non-NPSLE
patients with respect to gray and white matter structure are more sim-
ilar to HCs than to NPSLE patients (Appenzeller et al., 2007b; Jung et al.,
2010a,b). For example, Jung et al. investigating NPSLE patients and non-
NPSLE patients could identify regions of decreased white matter integ-
rity (decreased FA values) in NPSLE patients only (Jung et al., 2010b).
However, in statistical neuroimaging other factors than “true” differ-
ences (of outcome parameters, e.g. gray matter density/volume, FA
values, etc.), such as group size, acquisition parameters, preprocessing
steps and the way multiple comparisons are accounted for play a role
for whether differences are considered and reported as signiﬁcant or
not.
The aim of this study was to further investigate white matter integ-
rity in NPSLE and non-NPSLE in a cohort of 19 NPSLE patients, 19 non-
NPSLE patients and 18 HCs. We used FSL and the TBSS pipeline (tract
based spatial statistics) to preprocess and statistically analyze our data
performing both univariate and multivariate statistical tests. We hy-
pothesized that the pattern of altered white matter integrity in non-
NPSLE patients does not substantially differ from that seen in NPSLE pa-
tients. We also sought to speciﬁcally investigate the impact of alterna-
tive ways to correct for multiple comparisons that are frequently used
in statistical brain imaging. We hypothesized that the way statistical
maps are created has a profound inﬂuence on whether non-NPSLE pa-
tients have signiﬁcant alterations in white matter integrity.
2. Material and methods
2.1. Subjects
The study comprised 19patientswith acute NPSLE, deﬁned as one or
more neuropsychiatric manifestations within 2weeks prior to inclusion
in the study, and of 19 patients with SLE, without current or past history
of neuropsychiatric symptoms (non-NPSLE), as well as of 18 HCs. In a
recently published VBM study, we had reported differences in regional
gray matter volume between NPSLE patients, non-NPSLE patients and
HCs (Cagnoli et al., 2012). Some of these patients/subjects had also un-
dergone DTI and took part in current study. There were 19 female pa-
tients (out of 19) in the NPSLE group, 18 female patients (out of 19) in
the non-NPSLE group, and 16 females (out of 18) in the HC group. The
gender ratios did not differ signiﬁcantly between groups (Fisher's
exact test, p= 0.32).
The classiﬁcation of NPSLE was based on the 19 ACR case deﬁnitions
(American College of Rheumatology, 1999). In order to participate in
the study, individuals needed to fulﬁll 4 ormore of the ACR classiﬁcation
criteria (Tan et al., 1982) and, in order to qualify as an NPSLE patient,present within 2 weeks of the initial neuropsychiatric event. Patients
in the non-NPSLE group were required to have no prior history of neu-
ropsychiatric manifestations regardless of attribution. All participants
were recruited from the Department of Internal Medicine, Division of
Rheumatology, and the Department of Emergency Medicine at the Uni-
versity of Michigan. Patients with previous/known drug abuse, alcohol
abuse, diabetes, stroke and/or renal insufﬁciencywere excluded. Groups
were matched for age and sex. For details on patient groups and clinical
manifestation see Tables 1 and 2. The study had been approved of by the
IRB of the University of Michigan (HUM00000714) and informed con-
sent had been obtained from the patients prior to study inclusion.
All patients and HCs were submitted to a standardized clinical and
neurological examination including medical history (age, gender, eth-
nicity, age at disease onset, disease duration, etc.), physical examination
standard laboratory assessment and a Mini Mental State examination
(Folstein et al., 1975). SLE and NPSLE patients underwent required
laboratory tests to determine disease activity by the Systemic Lupus
Erythematosus Disease Activity Index (SLEDAI) (Bombardier et al.,
1992) as well as antiphospholipid antibody status. SLE was considered
active with a SLEDAI score >6. We chose this higher SLEDAI level to
minimize the inclusion of patients who have persistently active serol-
ogies (anti-DNA antibodies, low complements and /or leukopenia)
without clinical evidence of disease activity.
Disease duration was deﬁned as the time between the diagnosis of
SLE and the day of the MRI. CNS manifestations were divided into cen-
tral and peripheral following ACR case deﬁnitions. Cumulative damage
in both patient groups was assessed using the Systemic Lupus Interna-
tional Collaborating Clinics/American College of Rheumatology Damage
Index (SLICC) (Gladman et al., 1996) at the time of MRI acquisition.
With respect to age at disease onset, disease duration, SLEDAI, SLICC
and Mini-mental scores, non-NPSLE patients and NPSLE patients were
compared using the Mann–Whitney U test. Fisher's exact test was ap-
plied to compare gender and ethnic distribution in the three groups
(non-NPSLE, NPSLE and HCs). For details see Table 1.
Patients andHCswithMRI pathologies that affectedwhitematter in-
tegrity, such as cerebral infarcts or conﬂuent white matter lesions, were
excluded from the study. Other incidental ﬁndings that did not affect
whitematter did not lead to an exclusion (for a list of incidental ﬁndings
see Section 3.2). Small, unspeciﬁc white matter lesions were found in
both patients andHCs (see Results), theywere not consideredpatholog-
ical per se, as they are found in up to 45% of healthy people (Fazekas
et al., 1988; Schmidt et al., 1992), and did not lead to an exclusion of
the subject.
2.2. Data acquisition, pre-processing and analysis
MR imaging was performed at a 3 T MR scanner (Achieva, Philips,
Best, Netherlands). To rule out gross abnormalities such as acute or
old infarcts, hemorrhage, focal lesions or pathological contrast enhance-
ment and for any additional lesions not related to SLE, T2-w, FLAIR, T1-
weighted images pre and post contrast administrationwere acquired in
the same session and evaluated by an experienced neuroradiologist.
Lesion burden in form of whitematter T2/FLAIR hyper-intensive lesions
was deﬁned as mild (1–5 small white matter lesions), moderate (5–10
white matter lesions), or severe (>10 white matter lesions). Atrophy
was visually evaluated as none, mild, or severe.
dMRI images (15 gradient directions at b = 800 s/mm2, plus one
b= 0 image) of 19 NPSLE patients, 19 non-NPSLE and 18 healthy con-
trols (HCs)were acquired. Image pre-processing and statistical analyses
were performed using FSL 5, following the standard TBSS pipeline: eddy
current correction, linear regression of the diffusion tensor model, FA
estimation and non-linear normalization (FNIRT) were followed by
skeletonization of the group mean FA image. Thresholding at FA N 0.2
to restrict analysis to the white matter led to 122,477 mean skeleton
voxels, to which data from individual subjects was projected. A general
linear model was used to assess signiﬁcant differences between the
Table 1
Demographic data and disease severity.
NPSLE patients
n= 19
Non-NPSLE patients
n= 19
HC
n= 18
Signiﬁcance
Range
mean/SD
Range
mean/SD
Range
mean/SD
p value
Age 22–67
39.1/11.7
21–60
38.0/11.1
18–61
37.6/13.5
Kruskal–Wallis test
p= 0.99
Female patients 19 18 16 Fisher's exact test
p= 0.32
Ethnicity 1/19 Asian
5/19 AA
13/19 White
2/19 AA
17/19 White
1/18 Asian
17/18 White
Fisher's exact test
p= 0.072
Age at disease onset (years) 12–65
33.4/13.0
20–55
33.3/10.8
n/a Mann–Whitney U test
p N 0.99
Disease duration (years) 0.1–16
5.7/6.3
1.0–15
4.7/4.8
n/a Mann–Whitney U test
p= 0.95
SLEDAI 1–24
10.8/5.5
0–8
2.0/2.2
n/a Mann–Whitney U test
p b 0.0001
SLICC 0–2
0 68/0.67
0–3
0.47/0.84
n/a Mann–Whitney U test
p= 0.18
Mini Mental 22–30
27.8/2.6
24–30
28/1.5
n/a Mann–Whitney U test
p= 0.60
AA=African American; HC=healthy control; NPSLE= neuropsychiatric systemic lupus erythematosus; SD= standard deviation; SLE= systemic lupus erythematosus; SLEDAI= Systemic
Lupus Erythematosus Disease Activity Index; SLICC = Systemic Lupus Erythematosus International Collaborating Clinics; SD= standard deviation.
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included as a covariate of no interest.
To speciﬁcally investigate the impact of correcting formultiple com-
parisonswe applied three differentmethods. First we applied threshold
free cluster enhancement (TFCE), an alternative approach for control-
ling family wise error, implemented and recommended in version 5 of
FSL (Salimi-Khorshidi et al., 2011; Smith and Nichols, 2009). TFCE is a
voxel basedmethod; it resembles cluster-based analysis in that it boosts
the conﬁdence in the signiﬁcance of differences that are observed con-
sistently over large spatial neighborhoods, but avoids having to select
an initial cluster-forming threshold (for more details see below). Sec-
ondlywe applied themethod used in the paper by Jung et al. to facilitate
comparison, thresholding the t-statistic images from a General Linear
Model at t N 3.0, and testing the resulting clusters for statistical signiﬁ-
cance based on 10,000 Monte Carlo permutations for each group differ-
ence. We also performed the same procedure applying an initial voxel
threshold of t N 2.0, to further elucidate the impact of this initial thresh-
old on cluster statistics.
We ﬁnally performed a multivariate analysis, based on support
vector machines (SVMs). Speciﬁcally, we were interested whether we
could train a classiﬁer that could differentiate between the three groups
by identifying patterns of altered FA maps in SLE patients. Even if
classiﬁcation accuracy is below the level that would be required forTable 2
Differences in regional fractional anisotropy (TFCE corrected).
Comparison of groups Cluster size Coordinates Smallest p value
x y z
NPSLE b HC
7291 24 25 1 0.008
Non-NPSLE b HC
2660 –27 37 2 0.024
550 –17 0 38 0.038
258 18 34 12 0.039
NPSLE b non-NPSLE
− − − − −
HC = healthy control, NPSLE = neuropsychiatric systemic lupus erythematosus; non-
NPSLE = systemic lupus erythematosus without neuropsychiatric symptoms. TFCE =
threshold free cluster enhancement. Per-voxel p values, corrected for multiple compari-
sons, were computed using TFCE and permutation based statistics. Coordinates refer to
voxels with smallest p values within a cluster. Unlike cluster-based statistics, per-voxel
testing can lead tomany small clusters of signiﬁcant voxels. For brevity, only the ones larg-
er than 100 voxels are reported.computer-aided detection of the disease, classiﬁcation rates that are sig-
niﬁcantly greater than random chance conﬁrm that signiﬁcant differ-
ences exist between the successfully classiﬁed groups. Besides in cases
where only one of the two alternative methods for controlling family-
wise errors indicates a signiﬁcant difference between two groups, suc-
cessful classiﬁcation can serve as an additional conﬁrmation that this ef-
fect can be attributed to improved sensitivity, rather than to a false
positive detection. For classiﬁcation, we used projected FA values at all
122,477 skeleton voxels as a feature vector. We averaged the FA values
of each subject in the training dataset over the skeleton and used linear
regression on the resulting averages to estimate the effect of age. The
resulting slope and intercept were used to age-correct all feature values.
In order to reduce the impact of voxels less relevant to the classiﬁcation
task, each feature was weighted by its F score, as it would be used in a
two-sample F test. Classiﬁcation accuracy was estimated by training a
linear SVM on the resulting vectors in a leave-one-out manner; care
was taken to exclude test data from linear regression and feature
weighting via the F score. Multivariate analysis was performed within
the shogun toolbox (http://shogun-toolbox.org/).We usedpermutation
testing to check if accuracies were signiﬁcantly higher than random
chance. To this end, we built up a null distribution by computing
leave-one-out estimates of the accuracy of classiﬁers that were trained
on the same data with permuted labels. Overall our analyses comprised
the following steps:
1 The threshold free cluster enhancement (TFCE)method as implemented in FSL 5which
is based on pre-processing the t-statistic images using a nonlinear image transforma-
tion that boosts maxima with support from a spatial neighborhood before performing
a voxel-based permutation test to correct for multiple comparisons.
2 A cluster based method where group FA differences are calculated by thresholding the
t-statistic images at a cluster-forming threshold of t N 3.0 and controlling for multiple
comparisons on a cluster level using permutation methods with FSL's Randomize, run-
ning 10,000 Monte Carlo permutations for each of the group differences.
3 The same cluster-based method as in 3 with an initial cluster-forming threshold of t N
2.0.
4 A multivariate analysis to train a classiﬁer that could differentiate between the three
pairs of groups by identifying patterns of altered FA maps.
3. Results
3.1. Patients
NineteenNPSLE and 19 non-NPSLEpatients, aswell as 18HCs partic-
ipated in the study. The three groups were matched by age and gender
and did not differ with respect to ethnicity (for details see Table 1).
Table 4
Differences in regional fractional anisotropy (cluster corrected with voxel threshold t N 2.0).
Comparison of groups Cluster size Coordinates p value
x y z
NPSLE b HC
1683 24 26 2 0.001
1382 –24 31 5 0.002
Non-NPSLE b HC
536 –6 26 –1 0.027
NPSLE b non-NPSLE
− − − − −
HC = healthy control, NPSLE = neuropsychiatric systemic lupus erythematosus; non-
NPSLE = systemic lupus erythematosus without neuropsychiatric symptoms. In a ﬁrst
step voxels were thresholded at t N 2.0; permutation-based cluster statistics were then
computed to obtain amultiple comparison corrected p values for each cluster. Coordinates
refer to voxels with largest t values within a cluster.
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mined by the SLEDAI score (NPSLE: mean = 10.8 ± 5.5, non-NPSLE:
2.0 ± 2.2, p b 0.0001). There were no signiﬁcant differences between
age of disease onset (p N 0.99), disease duration (p= 0.95), and SLICC
scores (p = 0.18) between the two SLE groups. Mini-mental scores
werewithin normal ranges in both SLE groupswith no signiﬁcant differ-
ences (p= 0.60). For details see Table 1.
3.2. Conventional MRI analysis
On the conventional MRI a mild lesion burden was seen in 36.8%
(7/19), a moderate in 21.1% (4/19), and a severe in 10.5% (2/19) in
the NPSLE patients. A mild lesion burden was seen in 42.1% (8/19)
of the non-NPSLE patients, and a moderate lesion burden was seen
in 15.8% (3/19) of the patients. In the HC group 33.3% of study sub-
jects (6/18) had a mild lesion burden, 1 subject (5.6%) had a moder-
ate and 1 subject (5.6%) had a severe lesion burden. There were no
signiﬁcant differences in lesion load between the three groups:
non-NPSLE vs. HC, p = 0.55 (Fisher's exact test); NPSLE vs. HC:
p = 0.43, non-NPSLE vs. NPSLE: p = 0.61.
Mild atrophy was present in 8 of the 19 NPSLE patients and in 5 of
the 19 non-NPSLE patients. A few incidental ﬁndings were found
such as a small pineal cyst present in one NPSLE patient and a small
meningioma in another NPSLE patient, while a small venous angio-
ma was present in one non-NPSLE. A few incidental ﬁndings were
also found in the HCs; 4 venous angiomas and one right carotid ar-
tery aneurysm.
3.3. Voxel based analysis with threshold free cluster enhancement
The results of our statistical analyses are summarized in
Tables 2, 3 and 4, as well as Figs. 1 and 2. Analysis with TFCE re-
vealed several regions of decreased FA in prefrontal white matter
in SLE patients, both with and without neuropsychiatric symptoms.
In total in NPSLE patients 7429 skeleton voxels (at the 1 mm3 res-
olution used by TBSS) showed signiﬁcantly decreased FA values
as compared to HCs. Non-NPSLE patients had decreased FA values
in 3520 voxels. However, when we directly compared NPSLE and
non-NPSLE patients there were no signiﬁcant differences between
the two groups.
3.4. Cluster based analysis
Statistical analyses with cluster forming threshold t N 3.0 revealed
two regions, with 123 and 110 voxels in the prefrontal white matter
in each hemisphere, of decreased FA in NPSLE patients as compared to
HCs (p = 0.01 and p = 0.012). No signiﬁcant clusters were found
when comparing non-NPSLE patients to HCs or to NPSLE patients.
Thus,we observed a greatly reduced sensitivity of cluster-based analysisTable 3
Differences in regional fractional anisotropy (cluster corrected with voxel threshold t N 3.0).
Comparison of groups Cluster size Coordinates p value
x y z
NPSLE b HC
123 –24 31 5 0.010
110 24 26 2 0.012
Non-NPSLE b HC
− − − − −
NPSLE b non-NPSLE
− − − − −
HC = healthy control, NPSLE = neuropsychiatric systemic lupus erythematosus; non-
NPSLE = systemic lupus erythematosus without neuropsychiatric symptoms. In a ﬁrst
step voxels were thresholded at t N 3.0; permutation-based cluster statistics were then
computed to obtain amultiple comparison corrected p values for each cluster. Coordinates
refer to voxels with largest values within a cluster.as compared to TFCE.We hypothesized that this might be caused by the
fact that the large clusters found by TFCE are broken down into smaller
pieces by the arbitrary cluster-forming threshold, and that those indi-
vidual pieces are no longer signiﬁcant. We then repeated cluster-
based analysis with a reduced threshold of t N 2.0, which indicated spa-
tially muchmore extended regions of signiﬁcant FA change in NPSLE, as
compared to HCs (two clusters with 1683 voxel, p = 0.001, and 1382
voxels, p = 0.002), and re-introduced one cluster with signiﬁcantly
lower FA values (536 voxels, p = 0.027) in non-NPSLEs as compared
HCs. For more details see Tables 2 and 3 and Figs. 1 and 2.
3.5. Multivariate analysis
Classiﬁcation analyses revealed a better than chance classiﬁcation
when testing all SLE patients vs. HCs (79%, p= 0.001), NPSLE patients
vs. HCs (70%, p = 0.026), and non-NPSLE patients vs. HCs (70%, p =
0.020). We employed a permutation-based test, which helps to guard
against accidental double dipping and corrects for imbalanced class
sizes (e.g. when classifying all SLEs vs. HCs, an accuracy signiﬁcantly
higher than67%was tested). Using the samemethod, itwas not possible
to classify NPSLE vs. non-NPSLE patients (34% accuracy).
4. Discussion
In this study we applied DTI, using both univariate and multivariate
analysismethods, to determine differences inwhitematter integrity be-
tween SLE patients, with and without neuropsychiatric symptoms, and
a group of HCs. Applying voxel based statistics and using the TFCE
method to correct for multiple comparisons we found decreased FA
predominantly in prefrontal white matter in both NPSLE and non-
NPSLE patients as compared to HCs; we found no signiﬁcant differences
between the two SLE groups. However as compared to the HC group
NPSLE patients displayed about twice as many voxels with signiﬁcantly
reduced FA values as the non-NPSLE group. The implications of
our study are twofold: non-NPSLE patients do show alteration in
white matter integrity, although to a lesser degree than NPSLE patients.
Secondly for the categorical decision whether non-NPSLE patients are
more like NPSLE patients or more like HCs the choice of the statistical
test, speciﬁcally the correction for multiple comparisons plays a critical
role.
Our data are in line with other studies describing diminished white
matter integrity in NPSLE patients (Emmer et al., 2010; Jung et al.,
2010b; Zivadinov et al., 2013), suggesting that directed diffusion is
reduced in this patient group, which can possibly be attributed to local
pathologies or a combination of these. Possible mechanisms that have
been suggested are damage to the myelin, i.e. local demyelination,
damage to gray matter resulting in secondary axonal loss in the
white matter, or secondary involvement of the white matter due to re-
peated small vessel vasculitis and acute vessel wall inﬂammation
Fig. 1.NPSLE patients compared to healthy controls. A signiﬁcant reduction in regional fractional anisotropy in prefrontalwhitematterwas found inNPSLE patients as compared to healthy
controls (red voxels). Compared to TFCE or cluster-based analysis with cluster forming threshold t N 2.0, the partial extent of the reduction is strongly underrepresented with cluster
threshold t N 3.0.
295T. Schmidt-Wilcke et al. / NeuroImage: Clinical 5 (2014) 291–297(Bosma et al., 2000). Such inﬂammation of the small vessels of the brain
might then lead to vasculopathy and cause focal hypoperfusion or
microinfarcts that cause subtle changes, not visible on conventional MRI,
but detectable by DWI or DTI (Hughes et al., 2007; Luyendijk et al., 2011).
Furthermore our data suggest that non-NPSLE patients, although
clinically unaffected with respect to neuropsychiatric symptoms, also
display alterations in white matter structure, in terms of decreased FA
values in the prefrontal cortex, however to a lesser degree than NPSLE
patients. Non-NPSLE patients displayed about half as many voxels of
signiﬁcantly reduced FA as NPSLE patients.
Emmer et al. were the ﬁrst to apply DTI and TBSS in a cohort of 12
SLE patients and 28 HCs, reporting decreased FA values in variousFig. 2.Non-NPSLE patients compared to healthy controls. A signiﬁcant reduction in regional frac
No signiﬁcant differences were found with cluster threshold t N 3.0.regions such as the inferior fronto-occipital fasciculus, the fasciculus
uncinatus and the posterior limb of the internal capsule (corticospinal
tract), as well as in the anterior thalamic radiation (Emmer et al.,
2010). Importantly only 7 of these patients fulﬁlled the ACR criteria
for NPSLE, so that it is likely that non-NPSLE patients also contributed
to the group differences. Investigating a study sample comparable to
ours with respect to sample size and mean age, and applying the same
methodological approach, with a cluster forming threshold of t N 3.0
Jung et al. could identify regions of decreased FA only in NPSLE patients,
but not in non-NPSLE patients (Jung et al., 2010b). Furthermore two re-
gions showed decreased FA values in NPSLE patients as compared to
non-NPSLE patients, i.e. the left superior longitudinal fasciculus andtional anisotropy in prefrontal whitematterwas found in non-NPSLE patients (red voxels).
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(for multiple comparisons) method as in (Jung et al., 2010b) our results
were similar to those reported by Jung et al., i.e. we saw no differences
between non-NPSLE patients andHCs. For the following reasons, we be-
lieve that the more profound differences found by TFCE are genuine,
rather than false positives: ﬁrst, we could achieve similar results when
reducing the cluster-forming threshold. We note that there is no sys-
tematic or “correct” way of setting this threshold, and that it is one of
the main advantages of TFCE that it does not require such a threshold.
Its increased sensitivity compared to competing methods is one of the
beneﬁts claimed by TFCE (Smith andNichols, 2009); this claim is further
substantiated by the fact thatmultivariate analyses, using SVMs and the
leave-one-outmethod,were able to classify the two classes (non-NPSLE
andHC)with better-than-chance accuracy. Given the rather diffuse pat-
terns of altered FA in SLE, regardless of neuropsychiatric symptoms, we
did not expect a classiﬁer based on localized features to achieve highly
accurate classiﬁcation results. Rather, our motivation to use features
closely related to the quantities used in statistical testingwas to reafﬁrm
the signiﬁcant differences found by TFCE. Indeed, the accuracy to differ-
entiate between the two SLE groups andHCswas (as expected)modest,
but still signiﬁcantly better than randomchance, (non-NPSLEpatients−
HCs: 70%; and NPSLE patients−HCs: 70%). Differentiation between the
two SLE groupswas not possible (NPSLE patients – non-NPSLE patients:
34%). Against this background,we tend to think that the results revealed
by the TFCEmethod are valid and that reductions inwhitematter integ-
rity can be observed in both NPSLE patients and in non-NPSLE patients.
However, apart from the thresholding procedure other possible differ-
ences between previous studies and the current might explain, why so
far no signiﬁcant differences in the non-NPSLE have been reported;
these include local patient characteristics and differences in scanning
parameters. While we were not able to identify features that made
our sample somewhat special, the current study is the ﬁrst to apply
the TBSS algorithm on DTI data that were collected on a 3 T scanner,
with 15 gradient directions and thus might have caught subtle differ-
ences that escaped other scanning protocols. Importantly the lesion
load seen in this study is comparable to that seen in previous studies
showing a higher percentage of patients with a severe lesion load in
the NPSLE group, suggesting that both SLE groups are representative.
Different pathogenic pathways have been proposed for neuropsy-
chiatric manifestations in SLE and current research tries to identify
mechanisms that make SLE patients prone to CNS involvement. Often
neuropsychiatric symptoms occur early in the disease (NPSLE), which
for some authors speaks for an immune-mediated pathogenesis
(Steup-Beekman et al., 2013). As such CNS involvement might results
from a speciﬁc antibody proﬁle (Emmer et al., 2010; Matus et al.,
2007; DeGiorgio et al., 2001), possibly associated with a leakage of the
blood–brain-barrier (Huerta et al., 2006) or it might more generally re-
ﬂect a higher disease activity as compared to non-NPSLE. Given that
with respect to CNS involvement HCs and NPSLE patients are two
poles of one spectrum, ranging fromhealthy to severely ill, our data sug-
gest that non-NPSLE patients fall somewhere in between. In support of
this notion white matter lesions, as determined by conventional neuro-
radiological assessment have been described to occur in up to 60% of
non-NPSLE patients (Cotton et al., 2004) and cognitive dysfunction
has been reported to be present in 30% of non-NPSLE patients
(Monastero et al., 2001; Jung et al., 2012), both strongly suggesting ce-
rebral involvement despite the absence of neuropsychiatric pathologies
fulﬁlling ACR case deﬁnitions. One interesting question is howmany of
the non-NPSLE patients in our cohort would have shown cognitive dys-
function as determined by standardized neuropsychological testing.
This issue was not fully addressed, and can be seen as a limitation; as
such the Mini-Mental questionnaire with normal scores in both
SLE groups is not sensitive to detect subtle, but clinically relevant
dysfunctions.
The pattern seen in this study in both NPSLE and non-NPSLE very
much resembled each other; the other two studies applying DTI andTBSS however found partially overlapping, partially different regions
of diminished white matter integrity. All three studies could identify
prefrontal areas and parts of the internal capsula, on the other hand
none of the studies found FA decreases in the occipital lobe. Overall it
appears that SLE is associated with a rather diffuse pattern of decreased
FA. Against this background it will be of importance to further DTI stud-
ies to subclassify the study samples (i.e. NPSLE patients only with one
symptom, e.g. psychosis, acute confusional state) in order to identify
more symptom speciﬁc FA correlates.
There are a couple of limitations that need to be pointed out.
Although great care was taken to come up with study samples, that
did not differ in group size, age, and ethnicity, and despite SLE
group performance in the MMSE within normal ranges, and despite
no signiﬁcant differences in white matter lesion burden, we cannot
rule out that some of the differences seen in FA maps are associated
with differences in behavioral or biological parameters that had not
been assessed within the study. The characterization and work up
of patients and HCs in future studies will need to include more pa-
rameters (e.g. neuropsychological performance, mood) to further as-
sess the neurobiological correlates of FA alterations. Secondly small
white matter lesions were found in 8 out of 18 HCs (44%). Small
white matter lesions have been reported in up to 45% of healthy peo-
ple (Fazekas et al., 1988; Schmidt et al., 1992), possibly associated
with a higher risk of experiencing a stroke later in life. As such it
might be argued that the control group was not ideal. However,
HCs were healthy at the time point of scanning with no history/evi-
dence of cardiovascular risk factors or speciﬁc white matter disease
(e.g. leucodystrophies). Including only HCs, that had been deter-
mined post hoc to have absolutely no lesions, could have induced a
bias, possibly going along with false positive FA differences between
groups not related to the SLE status. Importantly white matter le-
sions and clusters of FA difference were not systematically found in
the same regions, supporting the notion that small white matter le-
sions occur independently from SLE associated decreases in FA
values.
5. Summary
Our data demonstrate changes in white matter integrity in terms
of decreased FA values, predominantly in the prefrontal cortex sug-
gesting cerebral involvement in NPSLE patients and to a lesser de-
gree in non-NPSLE patients. These ﬁndings go beyond the
unspeciﬁc white matter lesions reported to be present in up to 60%
of these patients group. Whether this pattern of diminished FA is
speciﬁc to SLE remains to be determined. Clinical and radiological
work up of SLE patients should be extended to include both neuro-
psychological testing and DTI in both NPSLE and non-NPSLE patients,
with the aim to speciﬁcally investigate neurocognitive dysfunction
on the one hand and reductions in white matter integrity on the
other hand. DTI with a scanning time between 8 and 12min, together
with advanced analysis methods, is generally suited to become part
of the routine neuroradiological work up facilitating the investiga-
tion and assessment of white matter in SLE patients, possibly even
providing at tool to support or discourage the diagnosis SLE and to
monitor subtle changes in white matter integrity over time not as-
sessable through conventional neuroimaging.
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